等待開盤 09-17 09:30:00 美东时间
0.000
0.00%
今日重点评级关注:Chardan Capital:维持Hyperion DeFi"买入"评级,目标价从7.3美元升至8.45美元;摩根大通:维持Vera Therapeutics"超配"评级,目标价从76美元升至83美元
09-09 15:36
UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $232 to $245.
09-09 00:58
Individuals in the U.S. can now add Humanity Biological Age's lab-informed insights to select health profile tests purchased through Quest's consumer-initiated testing platform LONDON, Aug. ...
08-25 20:00
Test to join the company's expansive portfolio of Quest AD-Detect® blood tests for assessing symptomatic patients Quest also launching a new multi-biomarker AD-Detect® lab-developed blood test with low 10% indeterminate rate, so more patients can receive an actionable insight SECAUCUS, N.J., Aug. 24...
08-24 19:27
Quest Diagnostics (DGX) declares $0.86/share quarterly dividend, in line with previous. Forward yield 1.45% Payable Oct. 21; for shareholders of record Oct. 6; ex-div Oct. 6. See DGX Dividend Scorecar...
08-13 05:00
SECAUCUS, N.J., Aug. 12, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cas...
08-13 04:15
今日重点评级关注:HC Wainwright & Co.:维持Q32 Bio"买入"评级,目标价从13美元升至36美元;Chardan Capital:维持ProMIS Neurosciences"买入"评级,目标价从20美元升至33美元
07-29 11:37
今日重点评级关注:HC Wainwright & Co.:维持居里"买入"评级,目标价从17美元升至43美元;花旗:维持Klaviyo"买入"评级,目标价从31美元升至34美元
07-27 14:02
Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $236 to $255.
07-24 19:33
华盛资讯7月24日讯,奎斯特诊疗公布2026财年Q2业绩,公司Q2营收30.43亿美元,同比增长10.2%,归母净利润3.20亿美元,同比增长13.5%。
07-24 04:40